Angiogenesis inhibitors showed no increased risk of arterial dissections or aneurysms in metastatic colorectal cancer patients. The study involved 34,733 patients, with 195 cases matched to 1950 ...

Oncologists have a variety of medicines they can use to treat cancer. Each drug works in a different way, so doctors often give patients different types of drug at the same time to deliver a one-two ...

Breast cancer, the most common cancer among women, is notorious for its ability to develop resistance to a wide range of treatments, including surgery, chemotherapy, targeted therapies, and ...

Within the tumor microenvironment, networks of cells and molecular signals form a dynamic landscape that drives disease ...

Purpose: We sought to determine whether venous thromboembolism in cancer patients is associated with aberrant plasma levels of hemostatic and angiogenic factors. Patients and Methods: Peripheral blood ...

"These white blood cells, frequently found in osteosarcomas, can promote tumor growth, angiogenesis and cancer metastasis [spread to other parts of the body] by suppressing the immune system's ability ...

Researchers from Washington University School of Medicine performed studies to assess the role of ZBTB46, a repressive transcription factor and a marker for classical dendritic cells (DCs), in tumor ...

In a study published in the journal of Biofunctional Materials, researchers from Wits Advanced Drug Delivery Platform (WADDP) Research Unit, Department of Pharmacy and Pharmacology, University of the ...

Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer “Unfit” for ...

A confocal microscopy image of mouse bone cancer, or murine osteosarcoma (outlined in gray), invading normal bone (blue). Peripheral nerves (green) and blood vessels (red) sprout around the tumor, ...